An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression (Q45260842)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2005
edit
Language Label Description Also known as
English
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
scientific article published in February 2005

    Statements

    An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit